About Strand Life Sciences
Strand Life Sciences is a genomics-based
research and diagnostics company with a
mission to improve global health by
decoding the genetic information contained
in an individual’s genome.
Strand Life Sciences partnership
programs enable large-scale
genomics research studies
Strand Life Sciences has partnered with
thousands of academicians and physicians
to apply next-generation genomics to
generate valuable insights into disease areas
such as cancer, cardiovascular and metabolic
diseases, eye and neurological disorders
What we do
Enabling genomic diagnostics for India and worldwide
We have revolutionized healthcare by reducing trial-and-error in treatment through the application of diagnostics and genomic testing through our innovative laboratory tests, technology, and platform solutions used by clinicians for their patients, scientific researchers, as well as pharmaceutical and biotech companies.
We provide end-to-end
solution for genomic testing
services in the areas of cancer
and rare diseases.
Research and Development
Global Leader in Bioinformatics Solutions
For close to 2 decades, we have been at the forefront of developing robust and sophisticated bioinformatics solutions based on our proprietary platforms Ramanujan and Avadis, for global pharmaceutical and leading research laboratories. Some of our developments include:
One of the foremost software
products built by Strand with 20,000
citations and used by 2000+
Strand Smart Lab
Complete turnkey solution that
with laboratory and informatics infrastructure/ support
to enable patient-centric genomic medicine.
Enables analysis of data
generated from next-generation
sequencing (NGS) experiments.
Providing clinical reports with deep insights and fast turn-around to global hospitals and genetic laboratories for making informed clinical decisions on their patient samples.
Choosing an accurate laboratory is pivotal
Certificate of Accuracy
Qualified Team at Work
The future belongs to precision medicine
Every day doctors make diffcult decisions while working with imperfect information. Every one of
these decisions is crucial and has an impact on the patients’ quality of life. That no two individuals
with the same symptoms—and even diagnosed with the same condition—respond identically to the
same therapy, only adds to the complexity.
Recognizing the limitations of the current one-size-fits-all approach, healthcare is rapidly moving
towards precision medicine, which uses genetic insights and advances in technology to provide a
deeper understanding of human physiology. Based on insights from analysis of large amounts of
clinical data, precision medicine can also reduce the cost of treatment by eliminating ineffective